Clinical trial for PTEN-deficient mets progressing on trastuzumab therapy
Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2 Overexpressing, PTEN-Deficient Metastatic Breast Cancer Progressing on Trastuzumab-Based Therapy
This study is currently recruiting patients.
Verified by M.D. Anderson Cancer Center May 2006